Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$VTGN

Vistagen Therapeutics, Inc. Common Stock

XNAS

$0.2828-4.78%$0.0142Prev $0.2970LIVE Full chart Live alerts
No recent price bars, the chart lights up when VTGN starts printing.

Why is VTGN down today? It is at $0.283 (-4.78%), and our scanner flagged it 59 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VTGN spikes, and full due diligence on VTGN — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $VTGN alerts the moment volume spikes

Our scanner flagged $VTGN 59 times in the last 30 days. Create a free account to track $VTGN, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$0.283
Change today
-4.78%
Previous close
$0.297
52-week range
$0.198 – $5.14
Valuation & dividend
Market cap
$12M
Ownership & volume
Shares outstanding
44.4M
Live vendor count
Insider ownership
3.3%
DEF 14A · 2026-07-31
Institutional own.
39.28%
Total held
42.5%
Tradeable float
25.5M
57% of shares · after 3% insiders + 39% institutions
Avg daily volume
2.0M
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
0.7x
15m
0.4x
1h
0.1x
1D
1.3x

Get free VTGN + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $VTGN down today?

1 alert today2.6x RVOLSEC filing

VTGN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on VTGN today, peaking at 2.6x its normal volume. Fresh from the SEC: Vistagen Therapeutics, Inc. filed an 8-K: Delisting / Listing Deficiency. A material company disclosure like this is often the real catalyst behind a move of this size.

Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →
Why is $VTGN moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileNot shortableSSR active · triggered Aug 05 (-11%)Borrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusHold2 analysts
Avg target $1.00(+254% upside)
Range $1 – $1
0 buy2 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying3 buys, 0 sells last 3 months (4/0 over 12 months)
Show 10 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Singh Shawn
Officer
Acquired (grant/award)+37K
0.09% of company
added 100%55K$7K
at $0.190
Jun 30, 26
Tressler Nick B.
Officer
Acquired (grant/award)+12K
0.03% of company
n/a12K$2K
at $0.190
Jun 30, 26
Adler Reid G.
Officer
Acquired (grant/award)+37K
0.09% of company
added 100%61K$7K
at $0.190
Jun 30, 26
Prince Joshua S.
Officer
Acquired (grant/award)+4K
0.01% of company
added 40%15K$2K
at $0.560
Dec 31, 25
Singh Shawn
Officer
Acquired (grant/award)+8K
0.02% of company
added 72%18K$13K
at $1.70
Jun 30, 25
Anderson Cynthia Lynn
Officer
Acquired (grant/award)+7K
0.02% of company
added 100%13K$11K
at $1.70
Jun 30, 25
Adler Reid G.
Officer
Acquired (grant/award)+8K
0.02% of company
added 46%24K$13K
at $1.70
Jun 30, 25
Prince Joshua S.
Officer
Acquired (grant/award)+5K
0.01% of company
added 82%11K$8K
at $1.70
Jun 30, 25
Anderson Cynthia Lynn
Officer
Acquired (grant/award)+3Kadded 72%6K$7K
at $2.51
Dec 31, 24
Prince Joshua S.
Officer
Acquired (grant/award)+3Kadded 100%6K$8K
at $2.51
Dec 31, 24

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$VTGN Sentiment

Bearish
Bearish9Bullish
📰 News: 0 bull · 4 bearToday: -4.8%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$VTGN Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 1h ago 2.6× RVOL
VTGN hit 2.642x RVOL at 11:11 AM ET
at $0.288
News· SEC EDGAR· 20h ago
Vistagen Therapeutics, Inc. filed an 8-K: Delisting / Listing Deficiency
Alert· 1d ago 6.2× RVOL
VTGN hit 6.185x RVOL at 9:59 AM ET
at $0.283
Alert· 1d ago -4.41%
$VTGN moved -4.41% in 1 min (Level 4) at 7:19 AM ET
at $0.275
Alert· 1d ago 11.9× RVOL
VTGN hit 11.921x RVOL at 7:19 AM ET
at $0.275
Alert· 1d ago +13.4% vs EMA
VTGN 200EMA (15m) Trending · 52 bars · L3 · +13.39% above EMA · slope +2.66%
at $0.298
Alert· 1d ago +5.6% vs EMA
VTGN 200EMA (5m) Trending · 103 bars · L4 · +5.60% above EMA · slope +1.10%
at $0.298
Alert· 1d ago +1.1% vs EMA
$VTGN near 200 EMA: +1.12% from 200 EMA at 4:57 PM ET
at $0.299
Alert· 1d ago +2.80%
$VTGN moved +2.80% in 1 min (Level 1) at 4:57 PM ET
at $0.305
Alert· 1d ago 40.6× RVOL
VTGN hit 40.586x RVOL at 4:57 PM ET
at $0.299
Alert· 1d ago +6.5% vs EMA
VTGN 200EMA (5m) Trending · 91 bars · L3 · +6.47% above EMA · slope +1.28%
at $0.299
Alert· 1d ago +3.8% vs EMA
VTGN 50EMA (1m) Trending · 53 bars · L3 · +3.85% above EMA · slope +1.82%
at $0.310
Alert· 1d ago +3.8% vs EMA
VTGN 50EMA (1m) Trending · 53 bars · L3 · +3.85% above EMA · slope +1.82%
at $0.310
Alert· 1d ago +1.9% vs EMA
VTGN 50EMA (1m) Trending · 55 bars · L3 · +1.86% above EMA · slope +1.81%
at $0.304
Alert· 1d ago 6.2× RVOL
VTGN hit 6.193x RVOL at 4:07 PM ET
at $0.315
Alert· 1d ago +8.05%
$VTGN moved +8.05% in 1 min (Level 1) at 4:05 PM ET
at $0.318
Alert· 1d ago 19.7× RVOL
VTGN hit 19.663x RVOL at 3:19 PM ET
at $0.299
Alert· 1d ago 30.5× RVOL
VTGN hit 30.491x RVOL at 2:47 PM ET
at $0.291
Alert· 1d ago 271.0× RVOL
VTGN hit 271.044x RVOL at 1:11 PM ET
at $0.274
Alert· 1d ago +0.4% vs EMA
$VTGN crossed above 200 EMA (+0.39% vs EMA) at 1:05 PM ET
at $0.295
Alert· 1d ago
The Watcher SOLD $VTGN at $0.2928 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"level_fail","shares":833,"instance":"Rider"}
at $0.293
Alert· 1d ago -1.0% vs EMA
$VTGN crossed below 200 EMA (-1.05% vs EMA) at 1:04 PM ET
at $0.291
Alert· 1d ago -0.2% vs EMA
$VTGN near 200 EMA: -0.25% from 200 EMA at 1:02 PM ET
at $0.293
Alert· 1d ago -5.67%
$VTGN moved -5.67% in 1 min (Level 1) at 1:02 PM ET
at $0.293
Alert· 1d ago 29.3× RVOL
VTGN hit 29.246x RVOL at 1:02 PM ET
at $0.291
Alert· 1d ago
The Watcher BOUGHT $VTGN at $0.2962 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · coil-under9","shares":833,"instance":"Rider"}
at $0.296
News· SEC EDGAR· 6d ago
Vistagen Therapeutics, Inc.: Vistagen Appoints Douglas J. Williamson to its Board of Directors
News· SEC EDGAR· 37d ago
Vistagen Therapeutics, Inc. filed an 8-K: Regulation FD Disclosure, Other Material Event
News· SEC EDGAR· 49d ago
Vistagen Therapeutics, Inc. filed an 8-K: Executive / Board Change
News· Benzinga· 65d ago Bearish
Kuehn Law Encourages Investors of Vistagen Therapeutics, Inc. to Contact Law Firm
News· GlobeNewswire Inc.· 144d ago Bearish
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - VTGN
News· GlobeNewswire Inc.· 147d ago Bearish
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
News· GlobeNewswire Inc.· 150d ago Bearish
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

VTGN stock FAQ

Why is $VTGN down today?

VTGN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on VTGN today, peaking at 2.6x its normal volume. Fresh from the SEC: Vistagen Therapeutics, Inc. filed an 8-K: Delisting / Listing Deficiency. A material company disclosure like this is often the real catalyst behind a move of this size.

What is the VTGN stock price today?

VTGN last traded at $0.283, down 4.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live VTGN alerts?

The VTGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VTGN 59 times in the last 30 days.

What exchange is VTGN on?

VTGN (Vistagen Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $12M.

Is VTGN good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VTGN for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.